ZEB1 and prostate carcinoma: Here we expand on our earlier studies and show that the mechanism of FLASH-dependent control of ZEB1 function is conserved in multiple cancer cell lines, including cervical, breast, pancreas and prostate cancer, and it is dependent on ZEB1 proteasomal degradation.